3,6-Dimethyl-2,3,3a,4,5,7a-hexahydro-1-benzofuran
Common Name: |
3,6-Dimethyl-2,3,3a,4,5,7a-hexahydro-1-benzofuran |
IUPAC Name: |
3,6-dimethyl-2,3,3a,4,5,7a-hexahydro-1-benzofuran |
Molecular Formula: |
C7H10N2O |
SMILES: |
CC1COC2C1CCC(=C2)C |
Inchi: |
1S/C10H16O/c1-7-3-4-9-8(2)6-11-10(9)5-7/h5,8-10H,3-4,6H2,1-2H3 |
Inchi Key: |
KBPPPUZMFQKLNP-UHFFFAOYSA-N |
Cas No: |
70786-44-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
138.17 |
Mass (g/mol) |
152.12 |
Molar Refractivity |
38.46 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
1 |
Rings |
2 |
TPSA |
35.01 |
Hetero Atoms |
1 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
207.00 to 208.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.331 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.43 |
LogP |
2.378 |
iLOGP |
1.98 |
XLOGP3 |
0.84 |
WLOGP |
1.10 |
MLOGP |
0.01 |
ESOL Log S |
-1.60 |
ESOL Solubility (mg/ml) |
3.44 |
ESOL Solubility (mol/l) |
0.025 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.16 |
Ali Solubility (mg/ml) |
9.6 |
Ali Solubility (mol/l) |
0.07 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.52 |
Silicos-IT Solubility (mg/ml) |
0.41 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.55 |
Bioavailability Score |
0.55 |
Caco2 |
|
Human Intestinal Absorption |
|
Plasm Protein Binding |
|
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
|
Acute Oral Toxicity |
|
Carcinogenicity (Binary) |
|
Carcinogenicity (Trinary) |
null |
Eye Irritation |
|
Hepatotoxicity |
|
Androgen Receptor Binding |
|
Aromatase Binding |
|
Estrogen Receptor Binding |
|
Glucocorticoid Receptor Binding |
|
Thyroid Receptor Binding |
|
BRCP inhibitor |
|
BSEP inhibitor |
|
OATP1B1 inhibitor |
|
OATP1B3 inhibitor |
|
OATP2B1 inhibitor |
|
OCT1 inhibitor |
|
OCT2 inhibitor |
|